G&L Scientific launches 'Bespoke', a new, tailor-made service for small and emerging pharma and biotech companies
G&L Scientific, a market-leading, multinational, scientific consultancy with over 25 years at the forefront of regulatory affairs and quality assurance, has launched a new, tailor-made service for small and emerging pharma and biotech companies.
Under the name Bespoke, this niche service will provide fully-integrated regulatory and quality support shepherding products through development and on to market.
Based and founded on many years of extensive practical experience with more than 2,500 consultants in over 100 countries, the team at G&L has a thorough understanding of the unique needs and demands of small and emerging companies and the challenges they face when seeking a suitable and appropriate service partner.
At the official launch, CEO of G&L Scientific, Stephen Loughrey, said: “I am proud and excited to introduce you to our new service, Bespoke. We have identified a real need within the industry for a one-stop, tailor-made service that can shepherd any product through all stages of development right through to getting it to market.
“Our clients will be accompanied every step of the way by our specially chosen team of experts, hand-picked for each piece of work depending on individual requirements. They will have unfettered 24/7 access to their assigned Bespoke Engagement Lead as well as individual members of their dedicated Bespoke Team who will provide the appropriate expertise based on client need.